AGP Picks
View all

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on November 5, 2026

Purple renews with Lucid Motors across its Riyadh operations
Resalis Therapeutics Announces First-in-Human Data for RES-010 Demonstrating Safety and Tolerability with Early Weight Loss Signals
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines
Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
ArrayPatch schließt eine überzeichnete Startkapitalfinanzierung in Höhe von 3,2 Millionen Euro ab, um die Entwicklung von Mikronadel-Therapeutika der nächsten Generation voranzutreiben
ArrayPatch boucle un tour de financement d’amorçage sursouscrit de 3,2 millions d’euros pour faire progresser ses traitements par micro-aiguilles de nouvelle génération
アレイパッチ、次世代マイクロニードル治療薬の開発推進に向け、応募超過の320万ユーロ (約5億6800万円) のシード資金調達を完了
어레이패치 (ArrayPatch), 목표액 초과한 320만 유로 규모 시드 투자 유치 완료…차세대 마이크로니들 치료제 개발 가속화
ArrayPatch 完成超額認購的 320 萬歐元種子輪融資,加速新一代微針療法研發
ArrayPatch Memuktamadkan Pusingan Pembiayaan Benih €3.2 Juta yang Menerima Lebihan Langganan untuk Memajukan Terapeutik Mikroneedle Generasi Seterusnya
ArrayPatch 完成超额认购、金额达 320 万欧元的种子轮融资,推进新一代微针疗法
ArrayPatch Completes Oversubscribed €3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics
X-SENSE XR0A-iR Smart Radon Detector Now Available on Lowes.com
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
Einride and Lorenz Bring Autonomous Fleet to Production Facility in Germany
Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus
9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Vermont Tech Scene

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.